Belite Bio Ownership | Who Owns Belite Bio?

Belite Bio Ownership Summary

Belite Bio is owned by 2.64% institutional investors, 44.40% insiders, and 52.96% retail investors. Darwin global management is the largest institutional shareholder, holding 9.12% of BLTE shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 0.89% of its assets in Belite Bio shares.

BLTE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Belite Bio	2.64%	44.40%	52.96%
Sector	Healthcare Stocks	50.47%	12.28%	37.25%
Industry	Biotech Stocks	49.08%	12.05%	38.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Darwin global management	3.06M	9.12%	$456.10M
Paradigm biocapital advisors lp	1.11M	3.32%	$177.74M
Ubs group	768.36K	2.29%	$122.51M
Rtw investments, lp	715.33K	2.13%	$114.05M
Millennium management	570.09K	1.70%	$90.89M
Holocene advisors, lp	494.50K	1.47%	$78.84M
Eventide asset management	357.65K	1.07%	$57.02M
Vestal point capital, lp	312.50K	0.96%	$23.13M
Deerfield management company, l.p. (series c)	304.01K	0.91%	$48.47M
Price t rowe associates inc /md/	281.81K	0.84%	$44.93M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Darwin global management	3.06M	12.10%	$456.10M
Paradigm biocapital advisors lp	1.11M	3.63%	$177.74M
Patient square capital lp	116.68K	3.30%	$18.60M
Verdad advisers, lp	13.81K	2.48%	$2.20M
Rtw investments, lp	715.33K	1.13%	$114.05M
Bioimpact capital	88.05K	1.08%	$14.04M
Vestal point capital, lp	312.50K	1.04%	$23.13M
Eventide asset management	357.65K	0.94%	$57.02M
Artia global partners lp	24.99K	0.88%	$3.98M
Pfm health sciences, lp	59.43K	0.86%	$9.48M

Top Buyers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	1.11M	3.63%	1.11M
Ubs group	768.36K	0.02%	639.61K
Holocene advisors, lp	494.50K	0.19%	410.43K
Vestal point capital, lp	312.50K	1.04%	312.50K
Price t rowe associates inc /md/	281.81K	0.01%	281.81K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-432.48K
Point72 asset management	-	-	-284.44K
Marshall wace, llp	-	-	-192.70K
Armistice capital	-	-	-167.93K
Perceptive advisors	-	-	-151.98K

New Positions

Holder	Shares	% Assets	Change	Value
Paradigm biocapital advisors lp	1.11M	3.63%	1.11M	$177.74M
Vestal point capital, lp	312.50K	1.04%	312.50K	$23.13M
Price t rowe associates inc /md/	281.81K	0.01%	281.81K	$44.93M
Patient square capital lp	116.68K	3.30%	116.68K	$18.60M
Duquesne family office	106.10K	0.50%	106.10K	$16.92M

Sold Out

Holder	Change
Pnc financial services group	-8.00
Quantbot technologies lp	-11.00
Tower research capital llc (trc)	-14.00
Td waterhouse canada	-70.00
Advisor group	-195.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	26	-61.76%	885,150	-87.69%	2	0.56%	15	-73.21%	7	-30.00%
Dec 31, 2025	37	8.82%	1,020,646	-55.40%	3	6.23%	27	-3.57%	8	60.00%
Sep 30, 2025	33	106.25%	2,288,468	3161.04%	7	15139.46%	28	180.00%	4	-20.00%
Jun 30, 2025	18	-	78,139	-47.79%	-	105.93%	12	-	5	-
Mar 31, 2025	18	-14.29%	149,657	-47.01%	-	56.18%	12	-14.29%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Eventide Healthcare & Life Sciences I	357.65K	0.89%	-25.44K
MEDICAL BioHealth EUR Acc	112.39K	0.28%	-55.00
Alger Small Cap Focus Composite	61.87K	0.15%	4.71K
Alger Small Cap Focus I	61.87K	0.15%	4.71K
HBM Healthcare Investments AG Ord	39.73K	0.10%	-39.13K
apo Medical Opportunities R	25.30K	0.06%	-
BrighthouseI Morgan Stanley Discovery B	15.91K	0.04%	15.91K
SPDR® Portfolio Emerging Markets ETF	10.93K	0.03%	-
RIM Global Bioscience EUR	12.81K	0.03%	-
State Street® SPDR® Portfolio EM ETF	12.50K	0.03%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 12, 2026	Chuang Hao-Yuan	Chief Financial Officer	Sell	$40.27K
Aug 12, 2026	Chuang Hao-Yuan	Chief Financial Officer	Sell	$25.92K
Aug 12, 2026	Lin Yu-Hsin	Chief Executive Officer	Sell	$40.27K
Aug 12, 2026	Lin Yu-Hsin	Chief Executive Officer	Sell	$25.56K
Jun 18, 2026	Scholl Hendrik Peter	Chief Medical Officer	Sell	$175.35K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	4
2026 Q2	-	125
2026 Q1	-	-

BLTE Ownership FAQ

Who Owns Belite Bio?

Belite Bio shareholders are primarily institutional investors at 2.64%, followed by 44.40% insiders and 52.96% retail investors. The average institutional ownership in Belite Bio's industry, Biotech Stocks , is 49.08%, which Belite Bio falls below.

Who owns the most shares of Belite Bio?

Belite Bio’s largest shareholders are Darwin global management (3.06M shares, 9.12%), Paradigm biocapital advisors lp (1.11M shares, 3.32%), and Ubs group (768.36K shares, 2.29%). Together, they hold 14.73% of Belite Bio’s total shares outstanding.

Does Blackrock own Belite Bio?

BlackRock is not among the top 10 institutional shareholders of Belite Bio.

Who is Belite Bio’s biggest shareholder by percentage of total assets invested?

Darwin global management is Belite Bio’s biggest shareholder by percentage of total assets invested, with 12.10% of its assets in 3.06M Belite Bio shares, valued at 456.1M$.

Who is the top mutual fund holder of Belite Bio shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Belite Bio shares, with 0.89% of its total shares outstanding invested in 357.65K Belite Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools